Phyllis Gardner, M.D.
Dr. Gardner has spent over 25 years in academia, medicine and industry. She began her academic medical career in 1984 at Stanford University, where she has held several positions including Senior Associate Dean for Education and Student Affairs and remains today as Professor of Medicine. From 1994 to 1998, she took a leave of absence to work at ALZA Corporation, a major drug delivery company, as a Principal Scientist, Vice President of Research and as Head of ALZA Technology Institute. She has received numerous national awards and honors and serves on the board of directors of Revance Therapeutics, Inc. as well as the Harvard Medical School Board of Fellows. Dr. Gardner previously served on the board of directors of Parnell Pharmaceuticals Holdings Ltd.
Dr. Gardner also worked with Essex Woodlands from 1999 until 2014. Her expertise in pharmacology and drug delivery was invaluable to the firm in evaluating technology in this growing segment of the pharmaceutical sector. Dr. Gardner holds a B.S. from the University of Illinois, where she graduated Phi Beta Kappa and Phi Kappa Phi, and a Doctor of Medicine from Harvard Medical School, where she graduated Alpha Omega Alpha. She trained in internal medicine at Massachusetts General Hospital, followed by a Chief Residency at Stanford University Medical Center. She completed research fellowships at the College of Physicians and Surgeons at Columbia University and University College, London, U.K.